|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 26, 2020 06:13PM
|
|
Blood Brain Barrier Summit
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 29, 2020 11:55AM
|
|
Re: Proactive Article - new presentation on website
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 19, 2020 09:39AM
|
|
Aposense
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2021 06:06PM
|
|
Re: Would a functional cure for T1D affect RVX and T2D?
|
2
|
Resverlogix Corp.
|
Jan 17, 2021 05:10PM
|
|
75,000 options expired
|
2
|
Resverlogix Corp.
|
Aug 11, 2020 06:05PM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
2
|
Resverlogix Corp.
|
Jan 13, 2021 04:58PM
|
|
New Preprint Published Today - ACE2 inhibitors produce improved outcomes - SARS-CoV-2
|
2
|
Resverlogix Corp.
|
Apr 04, 2020 09:58AM
|
|
Re: For those who missed it live...
|
2
|
Resverlogix Corp.
|
May 13, 2021 10:51AM
|
|
Q1 financials posted
|
2
|
Resverlogix Corp.
|
May 17, 2021 10:34PM
|
|
Re: RVX Announces Update Webcast and Conference Call
|
2
|
Resverlogix Corp.
|
Jan 18, 2021 07:51AM
|
|
Insider - Option Expiry
|
2
|
Resverlogix Corp.
|
May 01, 2020 11:15PM
|
|
Re: Tweet from Dr. KKZ (our guy) on SARS - CoV - 2 relationship to CKD
|
2
|
Resverlogix Corp.
|
Apr 11, 2020 10:50AM
|
|
What is RVX worth?? - Constellation taken over (CNST)
|
2
|
Resverlogix Corp.
|
Jun 02, 2021 09:02AM
|
|
Re: New study in the Lancet regarding COVID 19 and blood clotting
|
2
|
Resverlogix Corp.
|
Jun 30, 2020 07:18PM
|
|
Re: The problem...as I see it ...further to my last
|
2
|
Resverlogix Corp.
|
Oct 18, 2020 11:20AM
|
|
Option #2 and Option #3 questions
|
2
|
Resverlogix Corp.
|
Oct 27, 2020 01:55PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers - RVXOT
|
2
|
Resverlogix Corp.
|
Jun 13, 2020 05:03PM
|
|
Denali is flying
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 04, 2020 02:50PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
2
|
Resverlogix Corp.
|
Dec 01, 2021 04:59PM
|
